Literature DB >> 12971231

Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results.

K Robin Yabroff1, Kathleen Shakira Washington, Amy Leader, Elizabeth Neilson, Jeanne Mandelblatt.   

Abstract

Cancer screening has increased dramatically in the United States, yet in some populations, particularly racial minorities or the poor, advanced disease at diagnosis remains high. One potential explanation is that follow-up of abnormal tests is suboptimal, and the benefits of screening are not being realized. The authors used a conceptual model of access to care and integrated constructs from models of provider and patient health behaviors to review published literature on follow-up care. Most studies reported that fewer than 75 percent of patients received some follow-up care, indicating that the promise of screening may be compromised. They identified pervasive barriers to follow-up at the provider, patient, and health care system levels. Interventions that address these barriers appear to be effective. Improvement of data infrastructure and reporting will be important objectives for policy makers, and further use of conceptual models by researchers may improve intervention development and, ultimately, cancer control.

Entities:  

Mesh:

Year:  2003        PMID: 12971231     DOI: 10.1177/1077558703254698

Source DB:  PubMed          Journal:  Med Care Res Rev        ISSN: 1077-5587            Impact factor:   3.929


  54 in total

Review 1.  Interventions to improve follow-up of abnormal findings in cancer screening.

Authors:  Roshan Bastani; K Robin Yabroff; Ronald E Myers; Beth Glenn
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

2.  Reducing referral delays in colorectal cancer diagnosis: is it about how you ask?

Authors:  Hardeep Singh; Laura A Petersen; Kuang Daci; Clyde Collins; Myrna Khan; Hashem B El-Serag
Journal:  Qual Saf Health Care       Date:  2010-06-27

3.  Performance of implementing guideline-driven cervical cancer screening measures in an inner-city hospital system.

Authors:  Daryl L Wieland; Laura L Reimers; Eijean Wu; Lisa M Nathan; Tammy Gruenberg; Maria Abadi; Mark H Einstein
Journal:  J Low Genit Tract Dis       Date:  2011-10       Impact factor: 1.925

4.  Effectiveness of a provider reminder on fecal occult blood test follow-up.

Authors:  Meaghan F Larson; Cynthia W Ko; Jason A Dominitz
Journal:  Dig Dis Sci       Date:  2009-03-03       Impact factor: 3.199

5.  Community-campus partnership in action: lessons learned from the DuPage County Patient Navigation Collaborative.

Authors:  Athena T Samaras; Kara Murphy; Narissa J Nonzee; Richard Endress; Shaneah Taylor; Nadia Hajjar; Rosario Bularzik; Carmi Frankovich; XinQi Dong; Melissa A Simon
Journal:  Prog Community Health Partnersh       Date:  2014

6.  Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial.

Authors:  Thomas D Sequist; Alan M Zaslavsky; Richard Marshall; Robert H Fletcher; John Z Ayanian
Journal:  Arch Intern Med       Date:  2009-02-23

7.  Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results.

Authors:  Hardeep Singh; Himabindu Kadiyala; Gayathri Bhagwath; Anila Shethia; Hashem El-Serag; Annette Walder; Maria E Velez; Laura A Petersen
Journal:  Am J Gastroenterol       Date:  2009-03-17       Impact factor: 10.864

8.  Timeliness of breast cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program, 1996-2005.

Authors:  Lisa C Richardson; Janet Royalty; William Howe; William Helsel; William Kammerer; Vicki B Benard
Journal:  Am J Public Health       Date:  2009-12-17       Impact factor: 9.308

9.  A Comparison of Different Intensities of Patient Navigation After Abnormal Mammography.

Authors:  Anne Elizabeth Glassgow; Yamile Molina; Sage Kim; Richard T Campbell; Julie Darnell; Elizabeth A Calhoun
Journal:  Health Promot Pract       Date:  2018-06-15

10.  Physician reminders to promote surveillance colonoscopy for colorectal adenomas: a randomized controlled trial.

Authors:  John Z Ayanian; Thomas D Sequist; Alan M Zaslavsky; Richard S Johannes
Journal:  J Gen Intern Med       Date:  2008-04-02       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.